Recently, Ducker et al. revealed that a small molecule SHMT inhibitor could block the growth of many types of human cancer cells through decreasing glycine import, especially in B cell lymphoma [20]. Here, SHMT1 is linked to B-cell non-Hodgkin lymphoma.